A randomized, placebo-controlled, double-blind, dose escalation study to evaluate the efficacy, safety and tolerability of the study drug BT971 in patients with rheumatoid arthritis receiving concomitant Methotrexate - n.a. A randomized, placebo-controlled, double-blind, dose escalation study to evaluate the efficacy, safe ...
A randomized, placebo-controlled, double-blind, dose escalation study to evaluate the efficacy, safety and tolerability of the study drug BT971 in patients with rheumatoid arthritis receiving concomitant Methotrexate - n.a. A randomized, placebo-controlled, double-blind, dose escalation study to evaluate the efficacy, safe ...
Active rheumatoid arthritis, functional class II-III MedDRA version: 9.1;Level: LLT;Classification code 10039073;Term: Rheumatoid arthritis Active rheumatoid arthritis, functional class II-III MedDRA version: 9.1;Level: LLT;Classification c ...
A randomized, placebo-controlled, double-blind, dose escalation study to evaluate the efficacy, safety and tolerability of the study drug BT971 in patients with rheumatoid arthritis receiving concomitant Methotrexate A randomized, placebo-controlled, double-blind, dose escalation study to evaluate the efficacy, safe ...
A randomized, placebo-controlled, double-blind, dose escalation study to evaluate the efficacy, safety and tolerability of the study drug BT971 in patients with rheumatoid arthritis receiving concomitant Methotrexate A randomized, placebo-controlled, double-blind, dose escalation study to evaluate the efficacy, safe ...
Active rheumatoid arthritis, functional class II-III. MedDRA version: 12.1;Level: LLT;Classification code 10039073;Term: Rheumatoid arthritis Active rheumatoid arthritis, functional class II-III. MedDRA version: 12.1;Level: LLT;Classification ...